Authors:
Campistol, JM
Garcia, S
Combalia, A
Sole, M
Ramon, R
Citation: Jm. Campistol et al., Symptomatic destructive spondyloarthropathy secondary to beta 2-microglobulin amyloidosis. Report of four cases, AMYLOID, 8(1), 2001, pp. 65-70
Authors:
Inigo, P
Campistol, JM
Lario, S
Piera, C
Campos, B
Bescos, M
Oppenheimer, F
Rivera, F
Citation: P. Inigo et al., Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-ss(1) plasma levels in a crossover trial in renal transplant recipients, J AM S NEPH, 12(4), 2001, pp. 822-827
Authors:
Esmatjes, E
Flores, L
Inigo, P
Lario, S
Ruilope, LM
Campistol, JM
Citation: E. Esmatjes et al., Effect of losartan on TGF-beta 1 and urinary albumin excretion in patientswith type 2 diabetes mellitus and microalbuminuria, NEPH DIAL T, 16, 2001, pp. 90-93
Authors:
Campistol, JM
Inigo, P
Larios, S
Bescos, M
Oppenheimer, F
Citation: Jm. Campistol et al., Role of transforming growth factor-beta(1) in the progression of chronic allograft nephropathy, NEPH DIAL T, 16, 2001, pp. 114-116
Authors:
Wagner, PD
Masanes, F
Wagner, H
Sala, E
Miro, O
Campistol, JM
Marrades, RM
Casademont, J
Torregrosa, V
Roca, J
Citation: Pd. Wagner et al., Muscle angiogenic growth factor gene responses to exercise in chronic renal failure, AM J P-REG, 281(2), 2001, pp. R539-R546
Citation: Jm. Campistol et Jm. Grinyo, Exploring treatment options in renal transplantation: The problems of chronic allograft dysfunction and drug-related nephrotoxicity, TRANSPLANT, 71(11), 2001, pp. SS42-SS51
Authors:
Caballeria, J
Bruguera, M
Sole, M
Campistol, JM
Rodes, J
Citation: J. Caballeria et al., Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein AI gene: Clinical and pathological features, AM J GASTRO, 96(6), 2001, pp. 1872-1876
Authors:
Canalejo, A
Almaden, Y
Torregrosa, V
Gomez-Villamandos, JC
Ramos, B
Campistol, JM
Felsenfeld, AJ
Rodriguez, M
Citation: A. Canalejo et al., The in vitro effect of calcitriol on parathyroid cell proliferation and apoptosis, J AM S NEPH, 11(10), 2000, pp. 1865-1872
Citation: Jm. Morales et Jm. Campistol, Hepatitis C virus infection and nephrology ERA-EDTA Post-Congress Symposium 8-10 September 1999 Toledo, Spain - Preface, NEPH DIAL T, 15, 2000, pp. 1-1
Authors:
Campistol, JM
Esforzdo, N
Barrera, JM
Morales, JM
Oppenheimer, F
Citation: Jm. Campistol et al., Hepatitis C virus-positive patients on the waiting list for transplantation: study, evaluation and treatment, NEPH DIAL T, 15, 2000, pp. 68-70
Authors:
Saurina, A
Vera, M
Pou, M
Pedret, JL
Darnell, A
Campistol, JM
Cases, A
Citation: A. Saurina et al., Non-convulsive epileptic status after administration of cefepime in patients with advanced chronic renal failure, NEFROLOGIA, 20(6), 2000, pp. 554
Authors:
Praga, M
Perez, JCR
Rodicio, JL
Jarillo, MD
Alcazar, JM
Vigil, A
Ortuno, J
Hernando, L
Marin, R
Villaro, J
Otero, A
Roldan, CG
Pascual, J
Campistol, JM
Morales, JM
Hernandez, E
de Alvaro, F
Castelao, AM
Citation: M. Praga et al., The Spanish Society of Nephrology Forum - Hyperfiltration nephropathy, NEFROLOGIA, 20(4), 2000, pp. 311-335
Authors:
Kreis, H
Cisterne, JM
Land, W
Wramner, L
Squifflet, JP
Abramowicz, D
Campistol, JM
Morales, JM
Grinyo, JM
Mourad, G
Berthoux, FC
Brattstrom, C
Lebranchu, Y
Vialtel, P
Citation: H. Kreis et al., Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients, TRANSPLANT, 69(7), 2000, pp. 1252-1260
Citation: Jv. Torregrosa et Jm. Campistol, Reflex sympathetic dystrophy syndrome in renal transplant patients. A mysterious and misdiagnosed entity, NEPH DIAL T, 14(6), 1999, pp. 1364-1365
Authors:
Campistol, JM
Esforzado, N
Martinez, J
Rosello, L
Veciana, L
Modol, J
Casellas, J
Pons, M
de las Cuevas, X
Piera, J
Oliva, JA
Costa, J
Barrera, JM
Bruguera, M
Citation: Jm. Campistol et al., Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronichepatitis C virus infection in haemodialysis patients. Pre- and post-renaltransplantation assessment, NEPH DIAL T, 14(11), 1999, pp. 2704-2709